APA (7th ed.) Citation

Frey, S. E., Lottenbach, K., Graham, I., Anderson, E., Bajwa, K., May, R. C., . . . Belshe, R. B. (2017). A phase I safety and immunogenicity dose escalation trial of plague vaccine, Flagellin/F1/V, in healthy adult volunteers (DMID 08-0066). Vaccine, 35(48), 6759-6765. https://doi.org/10.1016/j.vaccine.2017.09.070

Chicago Style (17th ed.) Citation

Frey, Sharon E., Kathleen Lottenbach, Irene Graham, Edwin Anderson, Kanwaldeep Bajwa, Ryan C. May, Steven B. Mizel, Aaron Graff, and Robert B. Belshe. "A Phase I Safety and Immunogenicity Dose Escalation Trial of Plague Vaccine, Flagellin/F1/V, in Healthy Adult Volunteers (DMID 08-0066)." Vaccine 35, no. 48 (2017): 6759-6765. https://doi.org/10.1016/j.vaccine.2017.09.070.

MLA (9th ed.) Citation

Frey, Sharon E., et al. "A Phase I Safety and Immunogenicity Dose Escalation Trial of Plague Vaccine, Flagellin/F1/V, in Healthy Adult Volunteers (DMID 08-0066)." Vaccine, vol. 35, no. 48, 2017, pp. 6759-6765, https://doi.org/10.1016/j.vaccine.2017.09.070.